EBV-Related Malignant Neoplasm — Trials

EBV-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

120 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (26)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06925555	Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS	not yet recruiting	Phase 2	25	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Sep 30, 2025	clinicaltrials
NCT05970627	Perioperative Chemotherapy Plus Toripalimab for Epstein-Barr Virus-associated Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma	not yet recruiting	Phase 2	30	Yu jirenOTHER	1	Aug 1, 2023